Thermo Fisher Scientific


Advances in GMP-grade Raw Materials for mRNA Therapeutics

In the podcast series, Thermo Fisher Scientific’s Sr. Product Manager, Linas Pupelis, will discuss latest development of critical raw materials required to support the synthesis of mRNA for therapeutic development. Today, mRNA therapies are one of the hottest drug classes and the development of an entirely new drug class is not without challenges. A major issue in this industry is lack of high-quality raw material that meet clinical research and manufacturing regulations. In this podcast, we will discuss how our TheraPure reagents, which is specifically designed and carefully manufactured following the principles of 21 CFR 210/211 and ICH Q7, can help build the solutions to today’s challenges.

Innovations for BioTech using Flow Cytometry

In this podcast series, Thermo Fisher Scientific’s Flow Cytometry Senior Product Manager, Jolene Bradford, will discuss innovations with instrumentation available for our BioTech customers using Flow Cytometry. Challenges facing BioTech customers using flow cytometry often involve obtaining reproducible results, reducing errors, and maximizing throughput to confidently reduce hands-on time. The need to move quickly and get it right the first time has driven development of new flow cytometry instrument solutions of interest in the BioTech field. In this podcast we will address how our instrument solutions are designed to meet these needs.

2020 Bio/Pharma Virtual Congress

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021***